Since elevated TAM (CD68+) infiltration in breast stroma has been negatively correlated with clinic-pathological features, such as tumor size, HR status, histologic grade, and age [95,96], it has been disclosed as a prognosis factor in breast cancer patients [97]. This evidence concerns the gene CD68 and neoplasm.